National Hemophilia Foundation

FEATURED

BDC 2020 Updates and Transition to Virtual

Important updates regarding NHF's 72nd Bleeding Disorders Conference.
We Stand With You

Discrimination is the greatest threat to a community built on belonging and acceptance. We are committed to being part of the solution.
BioMarin Releases Trial Updates in Lead Up to WFH Virtual Summit

The updated trial data from BioMarin have been submitted as a late-breaking abstract to the upcoming World Federation of Hemophilia (WFH) Virtual Summit to be held June 14-19, 2020.
COVID-19 Webinars and Newsletter Update

NHF will continue to provide information and resources to the bleeding disorder community on the COVID-19 pandemic.
Inhibitors: Coping During COVID-19

In this webinar, Drs. Tammuella Singleton and Tyler Buckner explain what you need to know, and what precautions you need to take if you have hemophilia with an inhibitor.
Accredited Gene Therapy Educational Opportunities Available Online Now

These continuing education activities are intended for hematologists, pediatricians, and other healthcare professionals who manage patients with hemophilia.
Playing It Safe: Coping During COVID-19

Many of us are looking for new ways to stay active during the COVID-19 pandemic, but it’s important to find an activity that works for you and your bleeding disorder.
Statement from Novo Nordisk on Rebinyn and COVID-19

BioMarin is working with health authorities and governmental regulatory agencies globally, to ensure the safety of all those involved in their clinical trial program, including enrolled participants, investigators, and staff.

© 2020 National Hemophilia Foundation All rights reserved.